Skip Nav Destination
Update search
NARROW
Publications
Format
Article Type
Date
Availability
Journal Articles
Ibrutinib Treatment in CLL Interrupts CD40 Signaling Capacity and Sensitizes CLL Cells to Venetoclax
Karoline Kielbassa, Marco Haselager, Danique Bax, Julie Dubois, Mark-David Levin, Peter E. Westerweel, Rebecka Svanberg, Carsten Utoft Niemann, Arnon P. Kater, Eric Eldering
Journal:
Blood
Blood (2021) 138 (Supplement 1): 1545.
Published: 2021
Advertisement intended for health care professionals